| For: | Liu XY, Pan HN, Yu Y. Clinical efficacy and safety of erlotinib combined with chemotherapy in the treatment of advanced pancreatic cancer: A meta-analysis. World J Gastrointest Surg 2024; 16(3): 921-931 [PMID: 38577077 DOI: 10.4240/wjgs.v16.i3.921] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9366/full/v16/i3/921.htm |
| Number | Citing Articles |
| 1 |
Ramy Habib, Erika Arnold, Tasin Obi, Franco J. Vizeacoumar, Shahid Ahmed. Targeted Therapy in Pancreatic Ductal Adenocarcinoma: Current Advances and Challenges. Current Oncology 2026; 33(8) doi: 10.3390/curroncol33080452
|
| 2 |
Petar Brlek, Vedrana Škaro, Nenad Hrvatin, Luka Bulić, Ana Petrović, Petar Projić, Martina Smolić, Parth Shah, Dragan Primorac. Advances in Precision Oncology: From Molecular Profiling to Regulatory-Approved Targeted Therapies. Cancers 2025; 17(21) doi: 10.3390/cancers17213500
|
| 3 |
Anna Chiara Siciliano, Stefania Forciniti, Helena Iuele, Federica Carnevali, Giuseppe Gigli, Loretta L. del Mercato. Metabolic sensing in 3D models of pancreatic ductal adenocarcinoma: probing pH, oxygen, and lactate dynamics to decode chemoresistance. Frontiers in Bioengineering and Biotechnology 2026; 14 doi: 10.3389/fbioe.2026.1926254
|